ISSN 2398-2969      

Escherichia coli


Synonym(s): E. coli




  • Kingdom: Eubacteria.
  • Phylum: Proteobacteria.
  • Class: Gammaproteobacteria.
  • Order: Enterobacteriales.
  • Family: Enterobacteriaceae.
  • Genus:Escherichia.
  • Species:coli.

Classification of enteritis-causingE. colistrains

  • Pathogenic E. coli strains are characterized into pathotypes based on virulence properties and serological characteristics:
    • EnterotoxigenicE. coli(ETEC):
      • Have fimbriae which they use to bind to enterocytes.
      • Produce two proteinaceous enterotoxins.
      • Non-invasive.
      • Do not leave the intestinal lumen.
      • Leading cause of diarrhea in children in the developing world.
      • Common cause of Travelers' diarrhea. 
    • EnteropathogenicE. coli(EPEC):
      • Lack fimbriae.
      • Does not produce enterotoxins.
      • Causes enteritis/diarrhea.
      • Uses an adhesin (intimin). 
      • Moderately invasive.
      • Elicits an inflammatory response.
      • Attaches to enteric epithelial cells and induces the effacement of microvilli (aka attaching and effacingE. coli).
      • Most common pathotype seen in rabbits.
      • Can be a cause of economic loss for the commercial rabbit industry due to diarrhea and mortality.
    • Shiga toxin producingE. coli(STEC):
      • Also referred to as verocytotoxin-producingE. coli(VTEC) or enterohemorrhagicE. coli(EHEC).
      • This pathotype is the one most commonly heard about in the news in association with foodborne outbreaks.
      • Has fimbriae.
      • Shiga-like toxin.
      • Moderately invasive.
      • Attaches to enteric epithelial cells and induces the effacement of microvilli (aka attaching and effacingE. coli).
    • EnteroaggregativeE. coli(EAEC):
      • Have fimbriae.
      • Non-invasive.
      • Produce hemolysin and enterotoxin.
    • EnteroinvasiveE. coli(EIEC) and diffusely adherentE. coli(DAEC):
      • Found only in humans.


  • Was originally namedBacterium coli commune.
  • Escherichia:named after Theodor Escherich (1857-1911) in 1919 who discoveredE. coliand its properties.
  • Latin:coli - colon.

Active Forms

This article is available in full to registered subscribers

Sign up now to obtain ten tokens to view any ten Vetlexicon articles, images, sounds or videos, or Login

Clinical Effects



  • Pathogenic and non-pathogenic strains ofE. coliinhabit the lower gastrointestinal tract of many animals.
  • Not commonly found in rabbit intestines (or found in low numbers).
  • Abundant in the environment.


  • Reproduces by binary fission.
  • Uses bacterial conjugation, transduction or transformation to transfer DNA: allows a horizontal spread of genetic material through a population. 
  • Conjugation may occur with other bacteria to allow exchange of plasmids, which may bear toxin genes, and other transposable element such as anti-bacterial resistance.


  • Fecal-oral route.

Pathological effects

  • Insufficient passive (colostral) immunity, ie neonates.
  • Poor environmental hygiene   →   build-up of pathogenic strain   →   may overcome normal levels of passive immunity.
  • Intensive farming methods   →   rapid transmission of pathogenic strains.
  • Age (>1 week old) because:
    • Normal flora not yet established.
    • Immature immune system.
  • Stress factors, eg changed environment, weaning, transport, overcrowding, poor diet   diseases of the growing rabbit  .

Virulence factors of pathogenicE. colistrains

  • O antigen: part of the lipopolysaccharide (LPS) layer:
    • O antigen.
    • Core region.
    • Lipid A - associated with septicemia and toxemia.
  • K antigen: capsular polysaccharide.
  • H antigen: flagellin.
  • Certain fimbriae are protein adhesins.
  • Alpha and beta hemolysins.
  • Siderophores.
  • Heat-labile and heat-stable enterotoxins:
    • LT enterotoxin is related to the cholera toxin in structure and function.
    • ST enterotoxin causes a secretion of fluid and electrolytes into the intestinal lumen. 
  • Verotoxin or Shiga-like toxins - inhibit protein synthesis in host cells.
  • Villous atrophy and malabsorption occurs as a result of the attachment and effacing EPEC which causes diarrhea and subsequent death.

Opportunistic infections

  • E. colistrains, normally regarded as non-pathogenic can cause opportunistic infections.

Other Host Effects

diseases associated withE. coli


Control via animal

  • Determine if you have normal colibacillosis   Colibacillosis   vs post-weaning colibacillosis:
    • Neonatal colibacillosis:
      • Commonly occurs between 1-14 days of age.
      • Watery diarrhea (stains perineum and abdomen yellow).
      • Possible to have 100% morbidity and mortality.
      • Subsequent litters of the doe may have passive immunity.
    • Post-weaning colibacillosis:
      • 4-6 week old rabbits.
      • Possible to have 50%+ mortality.
      • Rabbits that recover may not grow to full potential.
  • Death occurs in 5-14 days.
  • Disease process is limited to the cecum and colon.
  • Culture and sensitivity.
  • Antibiotic administration   Therapeutics: antimicrobials  .
  • Supportive and fluid therapy   Fluid therapy  .
  • Appropriate diet   Nutrition: dietary requirements  .
  • Appropriate husbandry and management.

Disease outbreaks ofE. colihave not been reported in pet rabbits.

Control via chemotherapies

  • MostE. colistrains are sensitive to a wide range of antibiotics but resistance, often plasmid-mediated is frequently encountered.
  • Treat individual rabbits based on the results of culture and sensitivity   Therapeutics: antimicrobials  .
  • Can use trimethoprim-sulfamethoxazole   Trimethoprim / sulfadiazine  30 mg/kg PO BID or enrofloxacin   Enrofloxacin  10 mg/kg PO BID, until the culture and sensitivity results are acquired.

Control via environment

  • Does not sporulate, therefore boiling and/or sterilization are effective.
  • Sanitize rabbit cages and their entire living areas.
  • Provide rabbits with an appropriate diet   Nutrition: dietary requirements  .


  • Provide rabbits with a high fiber diet   Nutrition: dietary requirements  .
  • Provide rabbits with a clean environment.
  • Provide rabbits with adequate living space: plenty of room for exercise and no overcrowding.
  • Decrease stress as much as possible.


  • Some vaccines are available for humans.
  • There are none that are currently commercially available for rabbits.

Other countermeasures

  • While awaiting culture and sensitivity results, administer aggressive supportive and fluid therapy   Fluid therapy  .
  • Prognosis is guarded and depends on severity of disease, strain ofE. coli, immune status of the rabbit, concurrent disease(s), types of co-pathogen(s), etc.
  • Success increases with early intervention.


This article is available in full to registered subscribers

Sign up now to obtain ten tokens to view any ten Vetlexicon articles, images, sounds or videos, or Login

Further Reading


Refereed papers

  • Recent references from PubMed and VetMedResource.
  • Ravikumar P et al (2014) Evaluation of induced mastitis in rabbits based on clinical parameters, direct microscopic somatic scell count and viable counts of E. coli in milk. J Cell Tissue Res 14 (2), 4367-4372.
  • Lord B (2012) Gastrointestinal disease in rabbits 2. Intestinal diseases. In Pract 34 (3), 156-162 VetMedResource.
  • Ibekwe A M, Grieve C M & Yang C H (2007) Survival of Escherichia coli O157:H7 in soil and on lettuce after soil fumigation. Can J Microbiol 53 (5), 623-635 PubMed.
  • Scaife H R, Cowan D, Finney J et al (2006) Wild rabbits (Oryctolagus cuniculus) as potential carriers of verocytotoxin-producing Escherichia coliVet Rec 159 (6), 175-178 PubMed.
  • Fotadar U, Zaveloff P & Terracio L (2005) Growth of Escherichia coli at elevated temperatures. J Basic Microbiol 45 (5), 403-404 PubMed.
  • García A & Fox J G (2003) The rabbit as a new reservoir host of enterohemorhagic Escherichia coliEmerg Infect Dis (12), 1592-1597 PubMed.
  • Blanco J E, Blanco M, Blanco J et al (1996) O serogroups, biotypes, and eae genes inEscherichia colistrains isolated from diarrheic and healthy rabbits. J Clin Microbiol 34 (12), 3101-3017 PubMed.
  • Whipp S C, Rasmussen M A & Cray W C Jr. (1994) Animals as a source of Escherichia coli pathogenic for human beings. JAVMA 204 (8), 1168-1175 PubMed.
  • Cullor J S (1995) Escherichia coli O157-H7: the silent danger. Vet Med 90 (1), 74-82 VetMedResource.
  • Dorn C R (1995) Escherichia coli O157-H7. JAVMA 206 (10), 1583-1585 PubMed.
  • Licois D (1992) [Enteropathogenic Escherichia coli from the rabbit]. Ann Rech Vet 23 (1), 27-48 PubMed.
  • Levine M M (1987) Escherichia coli that cause diarrhoea - enterotoxigenic, enteropathogenic, enteroinvasive, enterohaemorrhagic and enteroadherent. J Infect Dis 155 (3), 377-89 PubMed.

Other sources of information

  • Centers for Disease Control and Prevention (2015) E. coli (Escherichia coli).
  • Vella D (2013) Rabbits. Intestinal Disorders. In:Clinical Veterinary Advisor. Birds and Exotic Pets. Eds: Mayer J & Donnelly T M. Elsevier. pp 385-390. ISBN: 978-1-4160-3969-3.
  • Oglesbee B L & Jenkins J R (2012) Rabbits. Gastrointestinal diseases. In:Ferrets, Rabbits and Rodents: Clinical Medicine and Surgery. 3rd edn. Eds: Quesenberry K E & Carpenter J W. Philadelphia: W B Elsevier Saunders. pp 193-204. ISBN: 978-1-4160-6621-7.
  • O'Malley B (2005) Rabbits. In:Clinical Anatomy and Physiology of Exotic Species. Elsevier Saunders. pp 173-195. ISBN 0 7020 2782 0.

Can’t find what you’re looking for?

We have an ever growing content library on Vetlexicon so if you ever find we haven't covered something that you need please fill in the form below and let us know!


To show you are not a Bot please can you enter the number showing adjacent to this field

 Security code